Shanghai's first nucleic acid industrial park will start in the Shanghai Hangzhou Bay Economic and Technological Development Zone in the middle of this month.
Comprehensive China CCTV and China Securities Network reported that this 3 -square -kilometer nucleic acid industry characteristic park will create a 720 acres of first -time and first -line districts in the 720 acres of nucleic acid industry.
It is reported that before the layout of the nucleic acid industrial park, the Shanghai Hangzhou Bay Economic and Technological Development Zone (referred to as the development zone) had long been in the field of nucleic acid., Is the leading enterprise in the nucleic acid industry ecosystem in the development zone.
Zhaowei creatures are the world's largest oligonucleotide and gene monopolic companies, and they are also the "invisible champions" of the global nucleic acid industry chain.In June 2019, Zhaowei Biological 43 acres of oligonucleotide, modified body, and nucleic acid enzyme research and development and production bases started construction in the development zone, and were put into production in June 2021. It currently accounts for 70%of the global nucleic acid raw materials.1.5 billion yuan (RMB, the same below, about S $ 300 million).
The general term of the deoxyrum ribose and ribosaccharotic acid (RNA).Coronary virus nucleic acid detection is to detect whether the nucleic acid containing the virus in the sample swab is determined whether the crown disease is infected.
In the field of biomedicine, messenger RNA (MRNA) is a disruptive drug innovation technology that will break through tumor and infectious diseases.The epidemic has allowed the world to see the huge advantage of MRNA innovation technology in vaccine development, which has spawned the process of industrialization.
The biomedical industry is one of the three strategic pilot industries in Shanghai.At present, there are more than 20 biomedical companies in the development zone, and the annual output value of 6.42 billion yuan in 2021 has achieved an annual output value.